Southern California’s non-profit, regional healthcare system Hoag Hospital has forged a strategic alliance with precision oncology diagnosis firm Imagene to facilitate quick cancer diagnosis.

This partnership utilises Imagene’s expertise in rapid AI-based molecular profiling.

Imagene’s artificial intelligence (AI) technology can profile cancer biomarkers in minutes, from a digitised biopsy image, offering immediate oncology intelligence to physicians.  

Hoag Family Cancer Institute Molecular Pathology Services chief and study principal investigator Dr David Braxton said: “Traditional molecular biomarker testing is expensive and can take weeks for patients to receive their results.

“Imagene’s AI-based biomarker detection shows great promise for significantly reducing the waiting time for patients to begin targeted therapies.”

“I expect that this kind of technology can be deployed into every hospital in the US and lead to better and earlier cancer care for patients no matter where they live.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The partnership is aimed at boosting health equity by helping more patients gain access to quick and ‘accurate’ molecular analysis for personalised cancer care.

Imagene co-founder and CEO Dean Bitan said: “We are excited to collaborate with Hoag, a leading community-based hospital that shares our vision of making molecular profiling accessible to all patients who need it.

“By working together, we aim to prove the value of rapid molecular testing that empowers medical teams to navigate the patient journey and make informed decisions related to the complex clinical junctions in cancer care.”

In addition to cancer, Hoag provides healthcare services in neurosciences, spine, women’s health, digestive health, heart and vascular.